(Moderator) Michelle Sexton - Quality Control of Adult Use Cannabis in WA State: What's working and what is not- realistic approaches
Jahan Marcu, PhD - Method Development, Batch sampling, Sample Preparation for Analysis, and Regulatory Compliance Issues
Jeff Raber, PhD - Inhalation Studies as a Rational Basis for Cannabis Regulations
Tony Young, President of American Herbal Products Association
Jahan Marcu, Ph. D., is currently the Senior Scientist and Chief Auditor for Americans for Safe Access and the Patient Focused Certification (PFC) Program. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine (IACM). Dr. Marcu is the Director of Research and Development at Green Standard Diagnostics Inc. He received his Ph.D. for significant contributions to the study of the structure and function of the CB1 receptor, and the role of the endocannabinoid system in bone. Before earning his Ph.D., Dr. Marcu worked at the California Pacific Medical Center Research Institute studying the anti-cancer properties of compounds from the cannabis plant (Published in the Journal of Molecular Cancer Therapeutics) and on analytical Cannabis research projects in Holland. He is also an author of the American Herbal Pharmacopeia's Cannabis Monograph and one of the auditors for the Patient Focused Certification (PFC) program; an enforcement and oversight program that ensures that basic product safety protocols are followed at Cannabis operations. Dr. Marcu is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.
Dr. Jeffrey C. Raber received his B.S. in biochemistry from Lebanon Valley College, PA and subsequently a Ph.D. in organic chemistry from the University of Southern California with an emphasis on developing new synthetic methodologies useful in pharmaceutical drug discovery and development efforts. Dr. Raber studied plant phylogenetics of the RuBisCO enzyme while in college and was named to the USA Today 1997 All-USA College Academic Team for his research accomplishments in this area. While at USC he was awarded the Harold and Lillian Moulton Fellowship for his efforts on the construction of novel heterocycles and peptidomimetics utilizing a proprietary boron-based multicomponent condensation reaction.
Dr. Michelle Sexton is a Naturopathic Doctor and Executive Medical Research Director at the Center for the Study of Cannabis and Social Policy. She is the Founder and Chief Science Officer of Phytalab, the first WA State Cannabis testing facility. She was a paid contractor for the WSLCB to develop the laboratory certification process for I502. Dr. Sexton is a technical advisor and editor on the Cannabis Monograph, adopted for quality control guidance for I502 Cannabis. She is internationally known for her work, research, patient advocacy and industry leadership.
Mr. Tony Young has practiced law since 1974. He joined Kleinfeld, Kaplan and Becker as a partner in 2003. Previously, he was a partner with Wald, Harkrader & Ross, and then Piper Rudnick, LLP, all in Washington, DC. He has counseled and represented domestic and foreign manufacturers and distributors with respect to compliance and defense of matters under the statutes enforced by the Food and Drug Administration, the Consumer Product Safety Commission, the Federal Trade Commission, the Drug Enforcement Administration and the Environmental Protection Agency for forty years.